PRESS RELEASE – June 13, 2022 — Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) aka Johne’s disease that could save the New Zealand dairy industry upwards of $80m/year in lost production.
Pictor - Home of the PictArray, PictImager & Pictorial platformMODERN MULTIPLEXED TECHNOLOGY FOR INFECTIOUS DISEASE MANAGEMENT